Literature DB >> 15189762

Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus.

Luigi Brunetti1, Giustino Orlando, Lucia Recinella, Barbara Michelotto, Claudio Ferrante, Michele Vacca.   

Abstract

Adiponectin (Adipocyte Complement-Related Protein of 30 kDa, ACRP30) and resistin are adipocyte-derived polypeptide hormones playing a role in metabolic homeostasis. Their plasma levels are inversely (adiponectin) or directly (resistin) correlated to obesity and they have opposite effects on insulin sensitivity. Adipose tissue hormones such as leptin have been shown to modulate neurotransmitters which control feeding in the hypothalamus. We have studied the effects of adiponectin and resistin on dopamine, norepinephrine and serotonin release from hypothalamic neuronal endings (synaptosomes) in vitro. We have found that adiponectin does not modify either basal or depolarization-induced amine release, while resistin inhibits the stimulated release of dopamine and norepinephrine, leaving unaffected serotonin release. We can conclude that, similarly to leptin, but differently from adiponectin, the adipose tissue hormone resistin could affect the central mechanisms of feeding by inhibiting catecholamine release in the hypothalamus. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189762     DOI: 10.1016/j.ejphar.2004.04.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Hypothalamic resistin induces hepatic insulin resistance.

Authors:  Evan D Muse; Tony K T Lam; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

2.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 3.  Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects.

Authors:  Gayane Sargis Vardanyan; Hasmik Samvel Harutyunyan; Michail Iosif Aghajanov; Ruben Sargis Vardanyan
Journal:  Future Med Chem       Date:  2020-10-12       Impact factor: 3.808

Review 4.  Peptides from adipose tissue in mental disorders.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Maciej Pilecki; Barbara Kościelniak; Przemysław J Tomasik
Journal:  World J Psychiatry       Date:  2014-12-22

Review 5.  Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.

Authors:  X Huang; Z Yang
Journal:  J Endocrinol Invest       Date:  2015-12-12       Impact factor: 4.256

Review 6.  New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms.

Authors:  Nadia Ayala-Lopez; Stephanie W Watts
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

7.  The Role of Adipokines in Understanding the Associations between Obesity and Depression.

Authors:  Valerie H Taylor; Glenda M Macqueen
Journal:  J Obes       Date:  2010-07-28

8.  Central adiposity and the functional magnetic resonance imaging response to cognitive challenge.

Authors:  M M Gonzales; S Kaur; D E Eagan; K Goudarzi; E Pasha; D C Doan; H Tanaka; A P Haley
Journal:  Int J Obes (Lond)       Date:  2014-01-14       Impact factor: 5.095

Review 9.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

10.  Central resistin overexposure induces insulin resistance through Toll-like receptor 4.

Authors:  Yacir Benomar; Arieh Gertler; Pamela De Lacy; Delphine Crépin; Hassina Ould Hamouda; Laure Riffault; Mohammed Taouis
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.